Peri-implant peripheral giant cell lesionsreport of 13 new cases and comparative histological and immunohistochemical analysis with peripheral and central giant cell lesions

  1. Thayná-Melo-de Lima Morais 1
  2. Ciro Dantas Soares 1
  3. José Manuel Aguirre Urizar 2
  4. Javier Alberdi Navarro 2
  5. Oslei Paes de Almeida 3
  6. Fábio-Ramôa Pires 4
  1. 1 MSc, Oral Pathology, Department of Oral Diagnosis, Piracicaba Dental School, University of Campinas, Brazil
  2. 2 PhD, Oral Pathology and Medicine, Department of Stomatology II, University of the Basque Country (UPV/EHU), Leioa (Bizkaia), Spain
  3. 3 PhD, Oral Pathology, Department of Oral Diagnosis, Piracicaba Dental School, University of Campinas, Brazil
  4. 4 PhD, Oral Pathology, School of Dentistry, State University of Rio de Janeiro, Brazil
Revista:
Medicina oral, patología oral y cirugía bucal. Ed. inglesa

ISSN: 1698-6946

Año de publicación: 2019

Volumen: 24

Número: 6

Páginas: 2

Tipo: Artículo

DOI: 10.4317/MEDORAL.23088 DIALNET GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Medicina oral, patología oral y cirugía bucal. Ed. inglesa

Resumen

Few cases or peri-implant peripheral giant cell lesions (PGCL) have been reported in the literature. The aim of this study was to report 13 new cases of peri-implant PGCL and compare the expression of smooth muscle actin, Bcl-2 protein, GLUT-1, CD68, osteoprotegerin, receptor activator of nuclear factor kappa-B, Ki-67 and CD34 in these cases with PGCL and central giant cell lesions (CGCL). Clinical data were retrieved from the laboratory records and histological analysis was performed using HE-stained slides. Immunohistochemical reactions for the above mentioned antibodies were performed and digitally scored. Peri-implant PGCL mostly affected the posterior mandible of adult females. CD68 and Bcl-2 expressions were higher in conventional PGCL and CGCL than in peri-implant PGCL (p=0.033 for CD68 and p<.0001 for Bcl-2). Microvessel density was higher in conventional peripheral than in central and peri-implant PGCL (p=0.002). Proliferative index of the mononuclear cells showed no statistically significant differences comparing the three groups but it was higher in peri-implant PGCL. The current study demonstrated that peri-implant PGCL is more common in the posterior mandible of adult females. There were some differences in microvessel density, proliferative activity and expression of CD68 and Bcl-2 among conventional PGCL, peri-implant and CGCL. Further studies are encouraged to better understand these early findings.

Referencias bibliográficas

  • Chrcanovic, B,Gomes, C,Gomez, R. (2018). Peripheral giant cell granuloma: an updated analysis of 2824 cases reported in the literature. J Oral Pathol Med. 47. 454
  • Lester, SR,Cordell, KG,Rosebush, MS,Palaiologou, AA,Maney, P. (2014). Peripheral giant cell granulomas: a series of 279 cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 118. 475
  • Motamedi, MH,Eshghyar, N,Jafari, SM,Lassemi, E,Navi, F,Abbas, FM. (2007). Peripheral and central giant cell granulomas of the jaws: a demographic study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 103. 39-43
  • Lange, J,van den Akker, HP,van den Berg, H. (2007). Central giant cell granuloma of the jaw: a review of the literature with emphasis on therapy options. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 104. 603
  • Manor, E,Kachko, L,Brennan, PA,Bodner, L. (2013). Cytogenetics of central giant cell granuloma of the mandible. J Oral Maxillofac Surg. 71. 1541
  • Souza, PE,Mesquita, RA,Gomez, RS. (2000). Evaluation of p53, PCNA, Ki-67, MDM2 and AgNOR in oral peripheral and central giant cell lesions. Oral Dis. 6. 35
  • Liu, B,Yu, SF,Li, TJ. (2003). Multinucleated giant cells in various forms of giant cell containing lesions of the jaws express features of osteoclasts. J Oral Pathol Med. 32. 367
  • Varsha, VK,Hallikeri, K,Girish, HC,Murgod, S. (2014). Expression of CD34 and CD68 in peripheral giant cell granuloma and central giant cell granuloma: an immunohistochemical analysis. J Oral Maxillofac Pathol. 18. 341
  • Amaral, FR,Bernardes, VF,Duarte, AP,Pereira, NB,Vasconcelos, AC,Gomez, RS. (2011). Quantitative expression analysis of apoptotic/antiapoptotic genes and association with immunolocalization of BAX and BCL-2 in peripheral and central giant cell lesions of the jaws. Tumor Biol. 32. 997-1003
  • Soares, CD,Borges, CF,Sena-Filho, M,Almeida, OP,Stelini, RF,Cintra, ML. (2017). Prognostic significance of cyclooxygenase 2 and phosphorylated Akt1 overexpression in primary nonmetastatic and metastatic cutaneous melanomas. Melanoma Res. 27. 448
  • Hirshberg, A,Kozlovsky, A,Schwartz-Arad, D,Mardinger, O,Kaplan, I. (2003). Peripheral giant cell granuloma associated with dental implants. J Periodontol. 74. 1381
  • Bischof, M,Rabah, N,Lombardi, T. (2004). Peripheral giant cell granuloma. Int J Oral Maxillofac Implants. 19. 295
  • Cloutier, M,Charles, M,Carmichael, RP,Sándor, GKB. (2007). An analysis of peripheral giant cell granuloma associated with dental implant treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 103. 618
  • Hernandez, G,Lopez-Pintor, RM,Torres, J,de Vicente, JC. (2009). Clinical outcomes of peri-implant peripheral giant cell granuloma: a report of three cases. J Periodontol. 80. 1184
  • Ozden, FO,Ozden, B,Kurt, M,Gündüz, K,Günhan, O. (2009). Peripheral giant cell granuloma associated with dental implants: a rare case report. Int J Oral Maxillofac Implants. 24. 1153
  • Olmedo, DG,Paparella, ML,Brandizzi, D,Cabrini, RL. (2010). Reactive lesions of peri-implant mucosa associated with titanium dental implants: a report of 2 cases. Int J Oral Maxillofac Surg. 39. 503
  • Peñarrocha-Diago, MA,Cervera-Ballester, J,Maestre-Ferrín, F,Peñarrocha-Oldra, D. (2012). Peripheral giant cell granuloma associated with dental implants: clinical case and literature review. J Oral Implantol. 38. 527
  • Brown, AL,Camargo de Moraes, P,Sperandio, M,Borges Soares, A,Araújo, VC,Passador-Santos, F. (2015). Peripheral giant cell granuloma associated with a dental implant: a case report and review of the literature. Case Rep Dent. 2015. 697673
  • Jané-Salas, E,Albuquerque, R,Font-Muñoz, A,González-Navarro, B,Estrugo-Devesa, A,López-López, J. (2015). Pyogenic granuloma/Peripheral giant-cell granuloma associated with implants. Int J Dent. 2015. 839032
  • Ogbureke, EL,Vigneswaran, N,Seals, M,Frey, G,Johnson, CD,Ogbureke, KU. (2015). A peripheral giant cell granuloma with extensive osseous metaplasia or a hybrid peripheral giant cell granuloma-peripheral ossifying fibroma: a case report. J Med Case Rep. 9. 14
  • Pacifici, A,Carbone, D,Marini, R,Sfasciotti, GL,Pacifici, L. (2015). Clinical management of a peri-implant giant cell granuloma. Case Rep Dent. 2015. 1-7
  • Galindo-Moreno, P,Hernández-Cortés, P,Ríos, R,Sánchez-Fernández, E,Cámara, M,O'Valle, F. (2016). Immunophenotype of dental implant-associated peripheral giant cell reparative granuloma in a representative case report. J Oral Implantol. 42. 55-60
  • Atarbashi-Moghadam, F,Atarbashi-Moghadam, S,Namdari, M,Shahrabi-Farahani, S. (2018). Reactive oral lesions associated with dental implants. A systematic review. J Invest Clin Dent. 9. 12342
  • Scarano, A,Lorusso, C,Mortellaro, C,Limongelli, L,Tempesta, A,Favia, G. (2018). Peripheral giant cell granuloma associated with dental implants. J Craniofac Surg. 29. 196
  • Halperin-Sternfeld, M,Sabo, E,Akrish, S. (2016). The pathogenesis of implant-related reactive lesions: a clinical, histologic and polarized light microscopy study. J Periodontol. 87. 502
  • Ashley, JW,Shi, Z,Zhao, H,Li, X,Kesterson, RA,Feng, X. (2011). Genetic ablation of CD68 results in mice with increased bone and dysfunctional osteoclasts. PLoS One. 6. 25838
  • Peacock, ZS,Jordan, RCK,Schmidt, BL. (2012). Giant cell lesions of the jaws: does the level of vascularity and angiogenesis correlate with behavior?. J Oral Maxillofac Surg. 70. 1860
  • Pammer, J,Weninger, W,Hulla, H,Mazal, P,Horvat, R. (1998). Expression of regulatory apoptotic proteins in peripheral giant cell granulomas and lesions containing osteoclast-like giant cells. J Oral Pathol Med. 27. 267
  • Boyce, BF,Xing, L. (2008). Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys. 473. 139
  • Mueckler, M. (1994). Facilitative glucose transporters. Eur J Biochem. 219. 713